Posted on 9/9/20
Curavit Clinical Research and eMoyo USA Partner
Curavit Clinical Research, a virtual research organization, and eMoyo USA, LLC, the USA representative of eMoyo, a global leader in healthcare technology, today announced a partnership . . .
Posted on 9/9/20
Thermo Fisher Should Buy Quest To Fully Integrate Lab Testing
SummaryA Thermo Fisher - Quest Diagnostics merger would have numerous cost synergy and sales growth possibilities.Margins/returns for the businesses are similar, and a mostly-stock transaction would . . .
Posted on 9/9/20
CVS Health: Business Takes Off, Stock Remains A Riddle
SummaryThere seems to be no bearish argument justifying the current stock price - neither the competition nor the trouble brick-and-mortar stores are facing.The debt levels are . . .
Posted on 9/8/20
Ambu Awarded Contract with UroGPO for Single-Use Cystoscope
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a contract with UroGPO, the largest Group Purchasing Organization for urology . . .
Posted on 9/8/20
United Imaging Announces Research Collaboration with Massachusetts General Hospital
United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today that its artificial intelligence (AI) teams in Boston and Shanghai will collaborate . . .
Posted on 9/8/20
CANbridge Pharmaceuticals Agreement with UMass Medical School
BEIJING & CAMBRIDGE, Mass--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions, announced that it has expanded its gene . . .
Posted on 9/8/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political Pressure
With the U.S. presidential election scheduled around the same time that the first coronavirus vaccines will be up for potential authorization or approval by the Food . . .
Posted on 9/8/20
Relay Therapeutics: Heavily Backed Biotech Brains Trust Looks A Long-Term Buy
SummaryRelay Therapeutics IPO'd in mid-July, raising $400 million - the third-largest biotech IPO in history.The company's Dynamo technology allows it to minutely map the activities of . . .
Posted on 9/8/20
Moderna Pulling Back on Coronavirus Vaccine Trial Enrollment to Get More Minority Patients Involved
A world eager for progress on vaccines to guard against the SARS-CoV-2 coronavirus and/or COVID-19 might have to wait a bit longer for a breakthrough. The . . .
Posted on 9/8/20
Moderna Reports 71% Enrollment in Coronavirus Vaccine Trial
Moderna (NASDAQ:MRNA) continues to make progress enrolling patients in the phase 3 clinical trial testing its coronavirus vaccine, mRNA-1273. In its weekly update, the biotech said . . .
Posted on 9/3/20
Biofourmis Closes $100 Million Series C
Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing
Posted on 9/3/20
Why These 3 Coronavirus Stocks Are Falling This Week
Shares of COVID-19 vaccine developers Moderna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX), and Pfizer (NYSE:PFE) have fallen this week after presentations to the Centers for Disease Control (CDC) revealed . . .
Posted on 9/3/20
How You Might Own a Stake in Moderna's Coronavirus Vaccine Without Even Knowing It
Moderna (NASDAQ:MRNA) has sold a lot of doses of its coronavirus vaccine already. Granted, those sales hinge on regulatory approval or authorization for mRNA-1273. But we're . . .
Posted on 9/3/20
Where Will Moderna Be in 1 Year?
All eyes are on drug manufacturers in 2020 as they race to develop the first coronavirus vaccine. Globally, recorded cases of COVID-19 have surpassed 25 million, . . .
Posted on 9/2/20
AlloVir Reports Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today reported financial results for the second quarter ended . . .
Posted on 9/2/20
Agios Pharmaceuticals A Buy For Tibsovo, Mitapivat
SummaryTibsovo sales, after weakness during launch, are ramping nicely.The therapy's label is likely to continue to be expanded for IDH1 mutant cancers.Mitapivat, if approved for PKD, . . .
Posted on 9/2/20
Cardiologs Partners with MicroPort
The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders Cardiologs, a global leader in . . .
Posted on 9/1/20
HPOne and FDS Announce Strategic Partnership
HealthPlanOne, Inc. and FDS, Inc. announced today that they have formed a strategic partnership to provide support for pharmacies using the FDS platform and their patients seeking . . .
Posted on 9/1/20
Local Coverage Determinations for Implantable CGMs Announced by Three Medicare Administrative Contractors
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems . . .
Posted on 9/1/20
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement
FOSTER CITY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on . . .
Posted on 9/1/20
Mevion and Proton International to Partner
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems and Proton International announced today that they have signed a two-system contract to bring Mevion’s compact proton therapy solution to new . . .
Posted on 9/1/20
Clear Creek Bio Announces First Patient Dosed in Clinical Study of Brequinar in Hospitalized Patients with COVID-19
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Clear Creek Bio, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) . . .
Posted on 9/1/20
Selecta Biosciences Secures Up To $35 Million Debt Financing
Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform, ImmTOR
Posted on 8/31/20
Vor Biopharma and Metagenomi to Collaborate
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and Metagenomi, a gene editing company discovering breakthrough . . .
Posted on 8/31/20
Pyramid Biosciences Secures $28 Million in Funding
Pyramid Biosciences, Inc., a Boston-based biotechnology company developing new precision therapies focused on the modulation of cell surface receptors, today announced the close of $28 million . . .
Boston
